ECSP024336A - A PHARMACEUTICAL DOSE UNIT FORM OF THE TYPE OF RIGID CAPSULES CONTAINING LISINE CLONIXINATE, A PROCEDURE FOR PREPARATION AND THE USE OF SUCH DOSE UNIT AS ANALGESIC AND / OR INFLAMMATORY - Google Patents
A PHARMACEUTICAL DOSE UNIT FORM OF THE TYPE OF RIGID CAPSULES CONTAINING LISINE CLONIXINATE, A PROCEDURE FOR PREPARATION AND THE USE OF SUCH DOSE UNIT AS ANALGESIC AND / OR INFLAMMATORYInfo
- Publication number
- ECSP024336A ECSP024336A ECSP024336A ECSP024336A EC SP024336 A ECSP024336 A EC SP024336A EC SP024336 A ECSP024336 A EC SP024336A EC SP024336 A ECSP024336 A EC SP024336A
- Authority
- EC
- Ecuador
- Prior art keywords
- dose unit
- inflammatory
- analgesic
- procedure
- type
- Prior art date
Links
- 230000000202 analgesic effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000002775 capsule Substances 0.000 title 1
- 230000002757 inflammatory effect Effects 0.000 title 1
- 238000004090 dissolution Methods 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- CVNFYQCHAWFYQI-ZSCHJXSPSA-N clonixin lysine salt Chemical compound NCCCC[C@H](N)C(O)=O.CC1=C(Cl)C=CC=C1NC1=NC=CC=C1C(O)=O CVNFYQCHAWFYQI-ZSCHJXSPSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000007903 gelatin capsule Substances 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- 229960003763 lysine clonixinate Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229940124531 pharmaceutical excipient Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se describe una forma de unidad de dosis farmacéutica del tipo de cápsulas de gelatina rígida que comprende clonixinato de lisina pulverizado como ingrediente activo, junto a exipientes farmacéuticos compatibles. De este modo se evita la comprensión, lo que da como resultado una mejora en la disolución y biodisponibilidad con respecto a otras formas farmacéuticas. Se describe además un procedimiento para preparar dicha unidad de dosis y el uso como analgésico y antiinflamatorio de la misma. Al no necesitarse compactar la mezcla a punta de transformarla en una unidad comprimida, ni suspenderla dentro de un exicipiente oleoso, produce una disolución más rápida al comienzo. Se mejora así su disponibilidad inicial, la cual pueda ser aprovechada para obtener un efecto rápido en el tratamiento del dolor o condiciones inflamatorias.A pharmaceutical dosage unit form of the type of rigid gelatin capsules comprising powdered lysine clonixinate as an active ingredient is described, together with compatible pharmaceutical excipients. This avoids understanding, which results in an improvement in dissolution and bioavailability with respect to other pharmaceutical forms. A procedure for preparing said dose unit and the use as an analgesic and anti-inflammatory thereof is also described. Since it is not necessary to compact the mixture to transform it into a compressed unit, or suspend it into an oily participant, it produces a faster dissolution at the beginning. This improves its initial availability, which can be used to obtain a rapid effect in the treatment of pain or inflammatory conditions.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MXPA01011964 MXPA01011964A (en) | 2001-11-22 | 2001-11-22 | Rigid capsules pharmaceutical dose unit form containing lysine clonixinate, procedure for its preparation and the use of said dose unit as analgesic and/or anti-inflammatory. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP024336A true ECSP024336A (en) | 2003-05-26 |
Family
ID=33411824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP024336 ECSP024336A (en) | 2001-11-22 | 2002-11-19 | A PHARMACEUTICAL DOSE UNIT FORM OF THE TYPE OF RIGID CAPSULES CONTAINING LISINE CLONIXINATE, A PROCEDURE FOR PREPARATION AND THE USE OF SUCH DOSE UNIT AS ANALGESIC AND / OR INFLAMMATORY |
Country Status (9)
| Country | Link |
|---|---|
| BR (1) | BR0206122A (en) |
| CO (1) | CO5380015A1 (en) |
| CR (1) | CR6823A (en) |
| EC (1) | ECSP024336A (en) |
| GT (1) | GT200200218A (en) |
| MX (1) | MXPA01011964A (en) |
| PA (1) | PA8558401A1 (en) |
| PE (1) | PE20030546A1 (en) |
| UY (1) | UY27515A1 (en) |
-
2001
- 2001-11-22 MX MXPA01011964 patent/MXPA01011964A/en unknown
-
2002
- 2002-10-24 UY UY27515A patent/UY27515A1/en unknown
- 2002-10-24 GT GT200200218A patent/GT200200218A/en unknown
- 2002-10-28 PE PE2002001062A patent/PE20030546A1/en not_active Application Discontinuation
- 2002-11-15 CR CR6823A patent/CR6823A/en not_active Application Discontinuation
- 2002-11-19 EC ECSP024336 patent/ECSP024336A/en unknown
- 2002-11-20 CO CO02105290A patent/CO5380015A1/en not_active Application Discontinuation
- 2002-11-21 BR BR0206122A patent/BR0206122A/en not_active IP Right Cessation
- 2002-11-22 PA PA8558401A patent/PA8558401A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO5380015A1 (en) | 2004-03-31 |
| BR0206122A (en) | 2004-08-03 |
| UY27515A1 (en) | 2003-05-30 |
| CR6823A (en) | 2008-08-27 |
| PE20030546A1 (en) | 2003-08-12 |
| MXPA01011964A (en) | 2003-08-20 |
| PA8558401A1 (en) | 2003-07-28 |
| GT200200218A (en) | 2003-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ma et al. | A comprehensive review of natural products to fight liver fibrosis: Alkaloids, terpenoids, glycosides, coumarins and other compounds | |
| AR039744A1 (en) | METHODS AND DOSAGE FORMS TO INCREASE THE SOLUBILITY OF PHARMACOS COMPOSITIONS FOR CONTROLLED ADMINISTRATION | |
| ES2109899T1 (en) | METHOD, COMPOSITIONS AND KITS TO INCREASE ORAL BIOAVAILABILITY OF PHARMACEUTICAL AGENTS. | |
| AR065970A2 (en) | A SOLID ORAL PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMBINATION OF METFORMIN AND GLIBENCLAMIDE AND USE OF SUCH COMPOSITION | |
| BRPI0513200A (en) | use of an anti-igf-1r antibody in the preparation of a medicament for combined treatment for nonhematological malignancies | |
| ECSP083351A (en) | PHARMACEUTICAL COMPOSITIONS | |
| AR005281A1 (en) | ORAL PHARACEUTICAL COMPOSITION, PROCEDURES FOR ITS MANUFACTURE AND USE OF THAT PHARMACEUTICAL COMPOSITION FOR THE PREPARATION OF MEDICINES. . | |
| CR7500A (en) | DOSAGE FORMS OF AZITROMICIDE WITH REDUCED SIDE EFFECTS | |
| AR034813A1 (en) | PHARMACEUTICAL COMPOSITIONS AND USE OF THE SAME | |
| ES2542842T3 (en) | Composition comprising taurolidine and / or taurultam for the treatment of cancer | |
| AR040722A1 (en) | FORMULATIONS AND DOSAGE FORMS FOR THE CONTROLLED ADMINISTRATION OF TOPIRAMATO | |
| AR023806A1 (en) | USE OF A PEPTIDE MIXTURE FOR THE MANUFACTURE OF A THERAPEUTIC AGENT FOR PROFILAXIS AND / OR CANCER TREATMENT, PHARMACEUTICAL COMPOSITIONS AND VACCINES CONTAINING SUCH MIXTURE AND THE PROCEDURES FOR PREPARATION OF THESE COMPOSITIONS | |
| AR018862A1 (en) | PHARMACEUTICAL FORMULATION OF PROLONGED RELEASE, IMPROVED FOR THE ORAL ADMINISTRATION OF NEFAZODONA OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME; ORAL DOSAGE FORM THAT UNDERSTANDS AND USE OF SUCH FORMULATION TO PREPARE THE SUCH DOSAGE FORM | |
| DE50203456D1 (en) | DEUTERATED 3-PIPERIDINOPROPIOPHENONE AND MEDICAMENTS CONTAINING SUCH COMPOUNDS | |
| ES2804324T3 (en) | Compositions containing extracts of Curcuma longa and Echinacea angustifolia that are useful for reducing peripheral inflammation and pain | |
| PE20250018A1 (en) | PHARMACEUTICAL DOSAGE FORMS COMPRISING (4S)-24-CHLORINE-4-ETHYL-73-FLUORO-35- METHOXY-32,5-DIOXO-14-(TRIFLUOROMETHYL)-32H-6-AZA-3(4,1)-PYRIDINE-1(1)-[1,2,3]TRIAZOLE- 2(1,2),7(1)-DIBENZENEHEPTAPHANO-74-CARBOXAMIDE | |
| AR033403A1 (en) | USE OF REOVIRUS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO REDUCE A SOLID TUMOR MASS. | |
| AR035946A1 (en) | PHARMACEUTICAL COMPOSITIONS TO USE IN THE TREATMENT OF DISORDERS IN WOMEN PERIMENOPAUSIC, MENOPAUSIC OR POSMENOPAUSIC, AND USES OF SUCH COMPOSITIONS FOR THE PREPARATION OF MEDICINES | |
| AR036009A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF VISCERAL PAIN AND GASTROINTESTINAL DISORDERS THAT INCLUDE A BICYCLIC AMINO ACID COMPOUND AND USE OF THIS LAST TO MANUFACTURE SUCH PHARMACEUTICAL COMPOSITION | |
| PE20130782A1 (en) | PHARMACEUTICAL COMPOSITIONS CONSISTING OF PARACETAMOL AND THE PROCESS FOR THE PREPARATION OF THE SAME | |
| ECSP024336A (en) | A PHARMACEUTICAL DOSE UNIT FORM OF THE TYPE OF RIGID CAPSULES CONTAINING LISINE CLONIXINATE, A PROCEDURE FOR PREPARATION AND THE USE OF SUCH DOSE UNIT AS ANALGESIC AND / OR INFLAMMATORY | |
| RU2020108631A (en) | NEW SUPPLEMENTARY THERAPY FOR USE IN THE METHOD OF TREATMENT OF PROSTATE CANCER | |
| AR037542A1 (en) | PHARMACEUTICAL DOSE UNIT FORM OF THE TYPE OF RIGID CAPSULES CONTAINING LISINE CLONIXINATE, PROCEDURE FOR THE PREPARATION AND USE OF SUCH DOSE UNIT AS ANALGESIC AND / OR ANTI-INFLAMMATORY | |
| AR037543A1 (en) | METHOD FOR CANCER THERAPY AND PHARMACEUTICAL COMPOSITION | |
| AR062894A1 (en) | FORMULATIONS FOR THERAPEUTIC ESTIMULATION HORMONE THERAPEUTIC ADMINISTRATION (THS) |